DOA
FBT icon

D'Orazio & Associates’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

D'Orazio & Associates’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-26
Closed -$4K – 339
2019
Q1 		$4K Buy
+26
New +$3.74K ﹤0.01% 286

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

D'Orazio & Associates's FBT Position: Q2 2019 in Review

D'Orazio & Associates sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2019, closing a stake of 26 shares — an estimated $4K sold.

D'Orazio & Associates first reported a position in FBT in Q1 2019 and held it in 1 quarter. The position peaked at $4K in Q1 2019. 222 funds tracked by Wall St. Rank hold FBT as of Q2 2019.

  • D'Orazio & Associates reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2019 after selling out during the quarter.
  • D'Orazio & Associates sold 26 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2019, an estimated $4K.
  • D'Orazio & Associates first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2019 and held it in 1 quarter.
  • D'Orazio & Associates's First Trust NYSE Arca Biotechnology Index Fund position peaked at $4K in Q1 2019.
  • 222 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2019.

Based on D'Orazio & Associates's 13F filing for Q2 2019, filed 5 Aug 2019.